Cargando…

Editorial: Advances in molecular targeted therapies of urologic cancers

Detalles Bibliográficos
Autores principales:	Nitzsche, Bianca, Höpfner, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632722/ https://www.ncbi.nlm.nih.gov/pubmed/36338677 http://dx.doi.org/10.3389/fonc.2022.1062015

Ejemplares similares

Editorial: Personalized Medicine for Urological Cancers: Targeting Cancer Metabolism
por: Gunter, Jennifer H., et al.
Publicado: (2022)

Recent Advances in Medical Therapy for Urological Cancers
por: Yuasa, Takeshi, et al.
Publicado: (2022)

Editorial: Cancer Metabolism: Molecular Targeting and Implications for Therapy
por: Ganapathy-Kanniappan, Shanmugasundaram
Publicado: (2017)

Editorial: Advances of Targeted Therapy in Gynecologic Malignancies
por: Qiu, Haifeng, et al.
Publicado: (2022)

Editorial: Precision Medicine and Translational Research in Urological Oncology
por: Na, Rong, et al.
Publicado: (2022)

HDAC inhibitors with potential to overcome drug resistance in castration-resistant prostate cancer
por: Biersack, Bernhard, et al.
Publicado: (2022)

Editorial: The advances in proteomics and targeted therapy of malignant brain tumours
por: Chen, Anjing, et al.
Publicado: (2023)

Editorial: Advances in genetics and molecular diagnosis in colorectal cancer
por: Islam, Farhadul, et al.
Publicado: (2023)

Editorial: The application of artificial intelligence in diagnosis, treatment and prognosis in urologic oncology
por: Zhu, Xue-hua, et al.
Publicado: (2022)

Editorial: Nanomedicine in Cancer Targeting and Therapy
por: Longo, João Paulo Figueiró, et al.
Publicado: (2021)

Molecular Characterization and Clinical Relevance of Lysine Acetylation Regulators in Urological Cancers
por: Zhang, Jian, et al.
Publicado: (2021)

Editorial: Molecular influences in therapies in ovarian cancer
por: Restaino, Stefano, et al.
Publicado: (2022)

Synthetic Small Molecule Modulators of Hsp70 and Hsp40 Chaperones as Promising Anticancer Agents
por: Nitzsche, Bianca, et al.
Publicado: (2023)

Editorial: Molecular Targets and Therapeutic Strategies in Gynecological Cancers
por: Lu, Ziwen, et al.
Publicado: (2022)

Editorial: Novel Molecular Targets and Treatments for Gastroesophageal Cancer
por: Lam, Alfred King-yin, et al.
Publicado: (2022)

Editorial: Advancements in Molecular Diagnosis and Treatment of Melanoma
por: Palmieri, Giuseppe, et al.
Publicado: (2021)

Editorial: Advances in genetics and molecular diagnosis in colorectal, stomach, and pancreatic cancer
por: Vaccaro, Carlos Alberto, et al.
Publicado: (2022)

Editorial: Emerging strategies for cancer therapy targeting ferroptosis
por: Li, Manshan, et al.
Publicado: (2023)

Editorial: Advances in the Molecular Mechanisms in Gastrointestinal Tumorigenesis and Treatment
por: Zhang, Ruowen, et al.
Publicado: (2022)

Editorial: Molecular Advances in Diagnosis and Treatment of CNS Tumors
por: Zhang, Zhao-Hui, et al.
Publicado: (2020)

Editorial: Molecular genetics and therapeutic advances in renal carcinoma
por: Nanus, David M., et al.
Publicado: (2023)

Editorial: Recent advances of drug resistance research in colorectal cancer therapy
por: Ye, Chenyang, et al.
Publicado: (2022)

The Evolving Role of Radiotherapy for Pediatric Cancers With Advancements in Molecular Tumor Characterization and Targeted Therapies
por: Shen, Colette J., et al.
Publicado: (2021)

Editorial: Women in cancer molecular targets and therapeutics, volume II: 2022
por: Berindan-Neagoe, Ioana, et al.
Publicado: (2023)

Editorial: Cancer stem cells as attractive targets for breast cancer therapy
por: Ibrahim, Sherif Abdelaziz, et al.
Publicado: (2023)

Editorial: Targeting redox regulation and autophagy systems for cancer therapy
por: Zhang, Junmin, et al.
Publicado: (2023)

Editorial: Recent advances in cervical cancer radiotherapy
por: Varlotto, John Michael, et al.
Publicado: (2023)

Targeting c-Met in the treatment of urologic neoplasms: Current status and challenges
por: Su, Pengxiao, et al.
Publicado: (2023)

Editorial: Advances in the Systemic Therapy and Combined Modality Approaches for Head and Neck Cancer
por: Argiris, Athanassios, et al.
Publicado: (2019)

Editorial: Radiotherapy for esophageal cancer: Molecular mechanism and novel targets to improve radiosensitivity
por: Liu, Yanqing, et al.
Publicado: (2023)

Editorial: Unravelling the Role of HERVs in Cancer: Insights and New Targets for Therapy
por: Matteucci, Claudia, et al.
Publicado: (2022)

Editorial: Advances in radiotherapy for prostate cancer
por: Kamran, Sophia C., et al.
Publicado: (2022)

Long Noncoding RNA Small Nucleolar Host Gene: A Potential Therapeutic Target in Urological Cancers
por: Yang, Zitong, et al.
Publicado: (2021)

Editorial: Advances in Epithelial Ovarian Cancer: Model Systems, Microenvironmental Influences, Therapy, and Origins
por: Howell, Viive Maarika, et al.
Publicado: (2015)

Targeting integrin α5β1 in urological tumors: opportunities and challenges
por: Zhou, Xuming, et al.
Publicado: (2023)

Editorial: Advances in malignant pleural mesothelioma: Diagnosis, treatment, and molecular mechanisms
por: Mastromarino, Maria Giovanna, et al.
Publicado: (2023)

Editorial: Molecular advances in diagnosis and treatment of CNS tumors, volume II
por: Chen, Clark, et al.
Publicado: (2023)

Editorial: Current Perspectives, Challenges and Advances in Cell Based Therapies
por: Thakar, Monica S., et al.
Publicado: (2020)

Editorial: Emerging Biomarkers for NSCLC: Recent Advances in Diagnosis and Therapy
por: Malapelle, Umberto, et al.
Publicado: (2021)

Editorial: Molecular Biomarkers for Gastric Cancer
por: Hong, Xinqiang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fi746fm0bnmcun5lmoor1qmj52